Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
106.4 GBX | +1.38% | -9.41% | -7.44% |
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Short
FOU | Founder | 55 | 17-12-31 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
Iqbal Gill
CTO | Chief Tech/Sci/R&D Officer | - | - |
Arthur Wakeley
PRN | Corporate Officer/Principal | - | - |
Burleigh Abbott
PRN | Corporate Officer/Principal | - | - |
Kerin Williams
SEC | Corporate Secretary | 46 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Firth
BRD | Director/Board Member | 62 | - |
Ian Anton
CHM | Chairman | 64 | 22-03-27 |
Robert Barr
BRD | Director/Board Member | 65 | 22-03-27 |
Steven Hajioff
BRD | Director/Board Member | 58 | 22-03-27 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
James Short
FOU | Founder | 55 | 17-12-31 |
Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,208,903 | 21,738,143 ( 33.86 %) | 0 | 33.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-7.44% | 83.81M | |
+24.08% | 562B | |
-6.03% | 358B | |
+20.24% | 322B | |
+7.98% | 297B | |
+13.21% | 219B | |
+6.35% | 199B | |
-10.55% | 196B | |
-10.26% | 149B | |
-6.08% | 146B |
- Stock Market
- Equities
- CEL Stock
- Company Celadon Pharmaceuticals Plc